NCT06504914 Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors
| NCT ID | NCT06504914 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Illinois at Chicago |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2024-02-05 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2024-02-05 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hypertension and obesity are both major risk factors for cardiovascular disease (CVD), a leading cause of death for Black women in the United States. The investigators propose examining the feasibility and acceptability of the 12-week RN-CHeFRx (Real Nourishment and Cooking Healthy Food is Rx) intervention \- grocery delivery, cooking classes, and nutrition education - for Black women with hypertension and obesity to improve nutritious eating habits and blood pressure control.
Eligibility Criteria
Inclusion Criteria: * self-identified as Black or of African descent * female * ≥ 18 years old * baseline blood pressure ≥130/85 or diagnosed with hypertension and/or BMI ≥ 25 Exclusion Criteria: * inability to cook in their homes * cognitive deficits impeding the ability to participate or provide informed consent * current treatment for cancer * liver or renal disease * pregnancy * lack of English language proficiency
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06504914 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 99 Years, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06504914 currently recruiting?
Yes, NCT06504914 is actively recruiting participants. Contact the research team at slofto4@uic.edu for enrollment information.
Where is the NCT06504914 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06504914 clinical trial?
NCT06504914 is sponsored by University of Illinois at Chicago. The trial plans to enroll 24 participants.